{"title": "PDF", "author": "PDF", "url": "https://imperialbrc.nihr.ac.uk/wp-content/uploads/2022/02/Initiation-Q1-2020-21.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "REC Ref No. IRAS No. Name of Trial Date First Participant RecruitedDate Site InvitedDate Site SelectedHRA Approval DateDate Site Confirmed By SponsorDate Site ConfirmedNon- Confirmation StatusDate Site To StartReasons for delay correspond to: 20/WM/0115 Solitaire\u00e2\u00a2 With DIRECT Solitaire\u00e2\u00a2 Stroke08/04/2020 Neither 20/EM/0115 A randomised phase II proof of principle multi-arm multi- stage trial designed to guide the selection of interventions for phase III trials in hospitalised patients with safety and immunogenicity of a self-amplifying ribonucleic acid (saRNA) vaccine encoding the S glycoprotein An open-label, non-randomized extension study to evaluate the long-term efficacy, safety and tolerability of LNP023 Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress evaluate the safety and efficacy of tocilizumab in patients with Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u00e2\u00a2) in Participants with Moderate COVID-19 Compared to Treatment10/04/2020 27/03/2020 controlled study to evaluate the efficacy, safety, and tolerability of Rozanolixizumab in adult study participants with persistent or chronic primary immune thrombocytopenia (ITP)- TP000320/03/2020 25/03/2020 Neither 20/NE/0104 282007 A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u00e2\u00a2) in 25/03/202020/LO/0574 281827 Preventing Cardiac Complications of COVID-19 Disease with Early Acute Coronary Syndrome Therapy: and patient reported outcomes in people with HIV with symptoms of insomnia switching integrase inhibitor-based Open Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Multiple Dose Study to Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Randomized, Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nabpaclitaxel as Neoadjuvant Treatment in Patients immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms in Kawasaki disease20/02/2020 28/02/2020 Sponsor Trial of Conservative versus Liberal Oxygenation Targets in Critically Ill Children28/01/2020 28/01/2020 23/12/2019 randomised trial of heme arginate versus placebo to reduce delayed graft function in kidney transplant recipients22/01/2020 23/01/2020 Neither 20/YH/0090 278137 AN OPEN-LABEL, MULTICENTER, ROLLOVER STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF LONG- TERM ADMINISTRATION OF GANTENERUMAB Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of by gonorrhoeae22/01/2020 11/02/2020 Neither selective HDAC6 inhibition with KA2507 in advanced biliary tract cancer previously treated with standard of care the Efficacy and Safety of Vedolizumab in the Prophylaxis of Intestinal Acute Graft-Versus-Host Disease in dose-finding Phase 2 study to evaluate efficacy and safety of BAY 2433334 in patients following an acute Double-Blind, Placebo-Controlled 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic 18/WM/0275 211232 A prospective non-randomised multi-centre feasibility study to assess if patients with residual cancer following dual- targeted neoadjuvant chemotherapy treatment for HER2- positive, ER-negative early breast cancer can be identified by multiple ultrasound (US)-guided tumour bed core 10/03/2020 Neither 19/EE/0326 270902 A randomised double-blind placebo controlled phase 3 trial to evaluate the efficacy and safety of estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women Twin-Twin Transfusion Syndrome (USgHIFU-TTTS)03/12/2019 09/03/2020 Sponsor 19/YH/0351 270898 A phase 2, prospective, randomised, double-blind, placebo- controlled clinical study to assess the efficacy, safety, tolerability, and pharmacokinetics of SJX-653 in postmenopausal 14/09/2020 Neither CERM 20/08/2019 Sponsor 19/LO/1532 269933 A Phase II, multicenter, randomized, open label two arm study comparing the effect of crizanilumab + standard of care alone on renal function in sickle cell disease patients \u00e2\u00a5 16 years with chronic kidney disease due to sickle nephropathy18/09/2019 18/12/2019 06/12/2019 03/02/2020 04/02/2020 association between arterial spectral waveforms feature or flow profiles and arteriovenous fistula to the \u00e2\u20acbest in COHORT STUDY INVESTIGATING THE OUTCOMES AND SAFETY OF ATEZOLIZUMAB UNDER REAL-WORLD CONDITIONS IN PATIENTS TREATED IN 11/11/2019 14/11/2019 27/11/2019 Sponsor 19/LO/1583 271866 A Phase 2, Open Label, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Voxelotor Evaluate the Safety and Pharmacodynamics of Once-daily Oral IW-1701 in Patients OF MTL-CEBPA IN COMBINATION WITH A PD-1 INHIBITOR (PEMBROLIZUMAB) IN of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line 25/03/2020 19/LO/1776 266797 Evaluation of a single use point of care device for the diagnosis of influenza and other respiratory pathogens in clinical upper airway samples using to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of CTX- SPL9111 (a prospective international EKoSoNic\u00c2\u00ae registry Of the treatment and Clinical OUTcomes of patients Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late study to evaluate the safety of MEDI8897, a monoclonal antibody with an extended half-life against respiratory syncytial virus, in high risk children (MEDLEY)05/03/2019 safety, toleraribility pharmacokinetics, and Anti-tumor activity of TPX-0005 in PAtients with Advanced Solid Tumors fracture fixation in the elderly, controlled study evaluating point of care gastric lipase enhanced pH test strip to confirm correct nasogastric tube in and polycystic ovarian syndrome related Placebo- Controlled, Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in label, multi- cohort, multi-center phase II study evaluating the efficacy and safety of IPH4102 alone or in combination with chemotherapy in patients with Study of Cabozantinib in Combination with Nivolumab and Ipilimumab versus Nivolumab and Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor to Evaluate the Activity of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic, (PMF), Vera (PV) Myelofibrosis, or Post Essential single-arm, rollover study to evaluate long-term safety in subjects who have participated in other luspatercept (ACE-536) clinical Open-Label, Study to Evaluate the Efficacy and Safety of Fedratinib Compared to Best Available Therapy in Subjects with DIPPS-Intermediate or High-risk Primary Myelofibrosis, Post-Polycythemia Vera Randomised Clinical Trial of Therapeutic Interventions with the Potential to Improve Outcome in Adults with Acute Myeloid Leukaemia and High Risk Randomized, Double-Blind, Placebo Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Study of Fostamatinib Disodium patients with antiphospholipid syndrome, with or without SLE (RISAPS): a Double Study of Pembrolizumab Plus Gemcitabine/Cisplatin versus Placebo Plus Gemcitabine/Cisplatin as First-Line STING Agonist E7766 in Subjects pharmacodynamics, safety and tolerability single-arm, multicenter study to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancy harboring of dual long- acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART-only in treated primary HIV infection - A two-stage randomised phase II placebo controlled clinical trial14/01/2020 19/LO/0943 264067 (MK-3475) + versus Perioperative Placebo + Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease or and Safety Study of Firibastat (QGC001) Compared to Ramipril Administered Orally, Twice Daily, Over 12 Weeks to Prevent Left Ventricular Dysfunction after With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Pembrolizumab versus Cystectomy AG-348 in Adult Subjects With tolerance and assessment of LACTIN-V use in a cohort of pregnant women at increased Continuous Glucose Monitoring on Glycaemic Control in High-risk Adolescents and Young Adults with Insulin-treated Diabetes17/12/2019 21/02/2020 18/12/2019 Neither 19/EE/0168 262098 A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD- L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy of of OnTrack - a digital system for upper limb rehabilitation after stroke16/04/2019 11/07/2019 Preterm a ruCaparib combined with Nivolumab +/- Ipilimumab to augment response in homologous repair deficient patients with relapsed Ovarian, primary peritoneal and fallopian cervical intra-epithelial neoplasia: a trial of Selective Decontamination of the Digestive Tract in Intensive of Dexcom G6 real-time continuous glucose monitoring with a predictive hypoglycaemia alert function on the frequency, duration and severity of hypoglycaemia occurring before, during and after regular physical activity in people with type 1 diabetes11/12/2019 12/02/2019 study to evaluate the use of digital technologies and artificial intelligence (AI) to enhance surgical team training and performance in the operating theatre and to improve efficiency and 2 Conjugate (ADC), in Combination with Nivolumab, an Anti-PD-1 Antibody, for Subjects with HER2- Sponsor 19/LO/0431 253404 Assessment of the Accuracy of Continuous Glucose Sensors in People with Diabetes Undergoing evaluate the safety, tolerability, and effects of Livoletide (AZP-531), an unacylated ghrelin 19/LO/0063 255904 the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION24/04/2020 01/06/2020 19/LO/0062 255909 A study evaluating the efficacy and safety of ralinepag to improve treatment outcomes in PAH patients.24/04/2020 Clinical Trial to Evaluate the Safety and Pharmacokinetics of Inhaled GB002, and Assess Changes in Imaging and Biomarkers in Subjects with WHO Group 1 to produce better outcomes from critical illness (A2B Trial): A randomised, parallel group, allocation concealed, controlled, open, phase 3 pragmatic clinical and cost- effectiveness trial with of an onward HIV disclosure intervention for 18-25 year olds living with Local tumour for metastatic biomarkers of organ injury in patients having cardiac surgery using cardiopulmonary bypass: Propofol cardioplegia 18/LO/1400 250545 A prospective the efficacy and safety of the BlueWind RENOVA iStim\u00e2\u00a2 system for the treatment of patients overactive bladder18/07/2018 30/10/2019 Sponsor 17/EM/0440 230556 A randomised phase to evaluate the Duration of ANti- PD1 monoclonal antibody Study, of Neoadjuvant Olaparib in Patients with Platinum Sensitive Recurrent High Grade the ADAPT- Sepsis Trial.28/09/2017 Sponsor 19/LO/1253 A Phase 2, Multicenter, Double- Blinded, Sham-Procedure Controlled Trial of Renal Denervation by the Peregrine System\u00e2\u00a2 Kit , 03/08/2016 02/03/2020 16/07/2020 30/07/2020 Sponsor "}